KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Preferred Stock Liabilities (2023)

Historic Preferred Stock Liabilities for Palvella Therapeutics (PVLA) over the last 1 years, with Q4 2023 value amounting to $70.6 million.

  • Palvella Therapeutics' Preferred Stock Liabilities changed N/A to $70.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was $70.6 million, marking a year-over-year change of. This contributed to the annual value of $70.6 million for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q4 2023, Palvella Therapeutics' Preferred Stock Liabilities is $70.6 million.
  • In the past 5 years, Palvella Therapeutics' Preferred Stock Liabilities registered a high of $70.6 million during Q4 2023, and its lowest value of $70.6 million during Q4 2023.